Skip to content
OpenCapital
Get started

Indaptus Therapeutics, Inc. INDP Q3 2025 earnings

Reported November 12, 2025 · Before market open

Diluted EPS-$2.98Beat by $1.19
EPS estimate-$4.17

Next report

Aug 17, 2026 (in a month)
EPS estimate-$1.57

Versus estimates

Diluted EPS

Q1 2026-$0.23Beat by $1.64Q4 2025-$3.10Beat by $1.26
Q3 2025-$2.98Beat by $1.19
Q2 2025-$9.09Beat by $0.15Q1 2025-$8.96Beat by $2.52Q4 2024-$0.38Beat by $0.03

Ask the moment Indaptus Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Indaptus Therapeutics, Inc. report Q3 2025 earnings?
Indaptus Therapeutics, Inc. (INDP) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Indaptus Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Indaptus Therapeutics, Inc. reported diluted EPS of $-2.98 for Q3 2025.
Did Indaptus Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-4.17 by $1.19.
How did Indaptus Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 831.3% from $-0.32.
Where can I find Indaptus Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-021758) and the 10-Q periodic report (0001493152-25-021759) directly on SEC EDGAR. The filing index links above go to sec.gov.